Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Uncertainty-aware quantitative analysis of high-throughput live cell migration data.

PLoS computational biology·2026

Same author

Depth of neutrophil mobilization stratifies survival in ST-elevation myocardial infarction.

Nature cardiovascular research·2026

Same author

Patient-derived glioblastoma cultures preserve respiration phenotypes during ex vivo maintenance and show sex-associated differences in migration.

Acta neuropathologica communications·2026

Same author

Clinical, Dietary, Lifestyle and Genetic Factors Associated With Age at Onset of Esophageal Adenocarcinoma.

United European gastroenterology journal·2026

Same author

Generalization of ML Models Between ECG and VCG Representation.

Studies in health technology and informatics·2026

Same author

DicomShield: A Pseudonymization Proxy for the Secondary Use of Imaging Data in the Research Context.

Studies in health technology and informatics·2026

Search research articles

Related Experiment Video

Updated: May 27, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Improved Bevirimat resistance prediction by combination of structural and sequence-based classifiers.

J Nikolaj Dybowski¹, Mona Riemenschneider, Sascha Hauke

¹Department of Bioinformatics, Center of Medical Biotechnology, University of Duisburg-Essen, Universitaetsstr, 2, 45117 Essen, Germany. Dominik.heider@uni-due.de.

|November 16, 2011

Summary

Predicting resistance to Bevirimat, an HIV-1 maturation inhibitor, is crucial for personalized therapy. Combining structural and sequence data in machine learning models accurately identifies patients who may benefit from this antiretroviral drug.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Experiment Videos

Last Updated: May 27, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Area of Science:

Virology
Drug Resistance Studies
Computational Biology

Background:

Maturation inhibitors, like Bevirimat, are novel antiretroviral drugs targeting HIV-1 protein cleavage.
Resistance mutations can emerge, diminishing Bevirimat's efficacy.
Accurate prediction of resistance is vital for identifying suitable patients for Bevirimat therapy.

Purpose of the Study:

To develop and evaluate methods for predicting HIV-1 resistance to Bevirimat.
To identify key regions associated with Bevirimat resistance.

Main Methods:

Utilized machine learning techniques, specifically classifier ensembles.
Integrated both structural and sequence-based information for prediction.
Employed computational analysis to pinpoint resistance-associated regions.

Main Results:

Classifier ensembles combining structural and sequence data achieved accurate and reliable Bevirimat resistance predictions.
Successfully identified critical regions for Bevirimat resistance computationally.
Computational findings were consistent with existing experimental data.

Conclusions:

Machine learning effectively predicts HIV-1 resistance to maturation inhibitors like Bevirimat.
The development of new maturation inhibitors necessitates accurate prediction tools for personalized antiretroviral therapy.
These prediction tools are essential for optimizing treatment strategies with emerging drugs.